3San - Julian M, Aquerreta J D, Benito A, et al. Indications for epiphyseal preservation in metphyseal malignant bone tumors of children:Relationship between image methods and histological findings[J]. J Pediatr Orthop, 1999,19 (4) :543 - 548.
4Panuel M, Centet J C, Scheiner C ,et al. Physeal and epiphyseal extent of primary malignant bone tumons in childhood. Correlation of preoperative MR1 and the pathologic examination [ J ]. Pediatr Radiol, 1993, 23(6) :421 -424.
6Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here? [ J ] . Paediatr Drugs, 2008, 10(5):315-327.
7Goodman LS, Wintrobe MM, Dameshek W, et al. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders [ J ] . JAMA, 1984, 251(17):2255- 2261.
8Evans AE. Mitomycin C [ J ] . Cancer Chemother Rep, 1961, 14:1-9.
9Sullivan MP, Taylor G. L-Phenylalanine mustard as a treatment for metastatic osteogenie sarcoma in children [ J ] . J Pediatr, 1963, 63:227-237.
10Cortes EP, Holland JF, Wang JJ, et al. Doxorubicin in disseminated osteosarcoma [J]. JAMA, 1972, 221(10):1132-1138.
